Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Esco Lifesciences Group has acquired Allwin Medical Devices, a medical devices business in California. Esco Lifesciences Group acquisitions focus on assisted reproductive technology (ART) and in vitro fertilization (IVF) consumables, where Allwin Medical Devices supports fertility clinics with core workflow products. The medical devices acquisition strengthens Esco’s Medical portfolio in reproductive medicine, adding ART/IVF consumables to its broader equipment, imaging, and digital traceability capabilities. The add on acquisition is a strategic acquisition by a Singapore-based strategic buyer, with Allwin Medical Devices expected to continue operating under its established brand. Deal size was not disclosed, and the company will integrate Allwin Medical Devices as a key pillar within Esco’s global healthcare M&A footprint, including healthcare deals CA and CA acquisitions.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026